Ameriprise Financial Inc Ironwood Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 598,202 shares of IRWD stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

598,202

Previous 638,327 6.29%

Holding current value

$2.11 Million

Previous $4.16 Million 40.93%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.93 - $7.04 $157,691 - $282,480	-40,125 Reduced 6.29%	598,202 $2.46 Million
Q2 2024 Aug 14, 2024	BUY	$5.58 - $8.61 $144,633 - $223,171	25,920 Added 4.23%	638,327 $4.16 Million
Q1 2024 May 15, 2024	SELL	$8.32 - $15.45 $1.45 Million - $2.7 Million	-174,641 Reduced 22.19%	612,407 $5.33 Million
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $650,961 - $852,396	74,057 Added 10.39%	787,048 $9 Million
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $976,527 - $1.34 Million	118,367 Added 19.91%	712,991 $6.87 Million
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $370,094 - $425,058	-36,643 Reduced 5.8%	594,624 $6.33 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $250,196 - $303,035	24,127 Added 3.97%	631,267 $6.64 Million
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $312,582 - $392,464	31,574 Added 5.49%	607,140 $7.52 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $379,793 - $463,692	-37,455 Reduced 6.11%	575,566 $5.96 Million
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $6.45 Million - $7.43 Million	583,941 Added 2008.05%	613,021 $7.07 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $81,431 - $98,854	-7,675 Reduced 20.88%	29,080 $365,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $304,927 - $391,688	-28,078 Reduced 43.31%	36,755 $429,000
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $347,444 - $405,740	29,148 Added 81.68%	64,833 $846,000
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $14,925 - $19,258	-1,469 Reduced 3.95%	35,685 $459,000
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $335,872 - $440,646	37,154 New	37,154 $416,000
Q2 2020 Aug 14, 2020	SELL	$9.14 - $11.97 $547,568 - $717,110	-59,909 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $514,019 - $839,325	59,909 New	59,909 $605,000
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $83,764 - $173,220	-10,739 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $153,675 - $189,543	10,739 New	10,739 $199,000
Q1 2018 May 15, 2018	SELL	$11.13 - $13.63 $835,874 - $1.02 Million	-75,101 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$12.16 - $14.58 $14,142 - $16,956	-1,163 Reduced 1.52%	75,101 $1.13 Million
Q3 2017 Nov 07, 2017	BUY	$12.07 - $14.87 $920,506 - $1.13 Million	76,264	76,264 $1.2 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Ironwood Pharmaceuticals Inc Transaction History